InsidersTradesSigma
Track the CYTORI THERAPEUTICS, INC. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 5 February 2016 (Attribution). Among the most active insiders: Girao Tiago. All data is accessible without an account.
Analysts rate CYTORI THERAPEUTICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
CYTORI THERAPEUTICS, INC. es una empresa centrada en el desarrollo de terapias basadas en células madre y biomateriales. Se concentra en tratamientos para afecciones médicas como enfermedades cardíacas y lesiones de tejidos.